NAD+ for the brain, memory, and nerve health

What has been tested in people?

Trials have studied oral NR in people with mild cognitive impairment or subjective cognitive decline. These are different from a study of NAD+ infusions in healthy customers. The cited 2023, 2025, and 2026 reports explore safety, biomarkers, and cognitive outcomes; the work remains an evolving research area rather than a basis for a general treatment promise.

Did raising NAD prove better cognition?

A laboratory rise and a cognitive improvement are separate endpoints. The 2026 pilot reported increased blood NAD without significant improvement in its principal cognitive or whole-brain blood-flow outcomes. Small studies also have limited power and duration. A seller should not quote only the biomarker change while omitting the clinical result.

What about nasal delivery to the brain?

A delivery hypothesis does not establish benefit in Alzheimer's disease. Ask for a human study of the exact nasal formulation and relevant outcome. Findings from oral NR cannot fill that gap. The nasal-spray guide explains what the route label leaves unanswered.

See the dedicated reviews of Parkinson’s NR research and the long-COVID trial for the distinction between early biological signals and demonstrated symptom benefit.

Does NAD regenerate nerves?

Preclinical work, including research involving NR and chemotherapy-related neuropathy, is not proof that a consumer product repairs nerves in people. New numbness, weakness, or balance problems require clinical attention. An experimental mechanism should be described as research, not sold as a predictable recovery timeline.

How can you discuss the research with a clinician?

Bring the actual paper rather than only a headline. Ask whether the participants resemble your situation, what improved, what did not, and whether the formulation matches the proposed product. For a trial opportunity, use an official study record and discuss eligibility with the care team. Our research reading guide provides a framework for that discussion.

What does BR+NAD mean?

BR+NAD is also used as branding for a clinical protocol; it should not be confused with a laboratory compound whose name includes brominated NAD. The protocol publisher describes proposed mental-health and recovery uses. That description is provider advertising, not proof that the protocol treats dementia or other neurological disease. Ask for controlled human evidence for the exact condition and protocol, and do not replace established care on the basis of the branding.